Sartorius Stedim Biotech S.A. (SRTOY)
OTCMKTS · Delayed Price · Currency is USD
20.52
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Sartorius Stedim Biotech Market Cap
Sartorius Stedim Biotech has a market cap or net worth of $19.28 billion as of August 1, 2025. Its market cap has increased by 14.81% in one year.
Market Cap
19.28B
Enterprise Value
21.94B
Revenue
3.40B
Ranking
n/a
PE Ratio
72.91
Stock Price
$20.52
Market Cap Chart
Since March 13, 2008, Sartorius Stedim Biotech's market cap has increased from 737.16M to 19.28B, an increase of 2,515.94%. That is a compound annual growth rate of 20.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 19.59B | 3.04% |
| Dec 31, 2024 | 19.01B | -22.08% |
| Dec 29, 2023 | 24.40B | -18.13% |
| Dec 30, 2022 | 29.80B | -41.07% |
| Dec 31, 2021 | 50.57B | 54.01% |
| Dec 31, 2020 | 32.84B | 114.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.98M |
| Northwest Biotherapeutics | 351.67M |